.jpeg)
Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown strong results—Phase III trials demonstrated an average 12.4% body weight loss over 72 weeks, along with improved heart health markers like cholesterol and blood pressure
Expert care at The Vesey
CQC-regulated private hospital in Sutton Coldfield. 25+ specialties, 68 expert clinicians. Open 7 days, 8am–8pm. No waiting lists. Free parking.
Book an appointment